| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/23/2011 | CN1929824B Soft gelatin capsule comprising omega-3-polyunsaturated fatty acid |
| 03/23/2011 | CN1843393B Use of pharmaceutical composition containing aceglutamide and safflower |
| 03/23/2011 | CN101990436A Compositions and methods for treating neurodegenerative diseases |
| 03/23/2011 | CN101987847A Novel heterocyclic NF-kB inhibitors |
| 03/23/2011 | CN101987198A Medicinal composition |
| 03/23/2011 | CN101987176A Traditional Chinese medical preparation for treating headache |
| 03/23/2011 | CN101987175A Traditional Chinese medicine for treating diabetic gastroplegia |
| 03/23/2011 | CN101987174A Traditional Chinese medicine for treating diabetic peripheral neuropathy |
| 03/23/2011 | CN101987160A Traditional Chinese medicine preparation for treating psoriasis and neurodermitis |
| 03/23/2011 | CN101987148A Chinese herbal medicine prescription for treating facial neuritis and preparation method thereof |
| 03/23/2011 | CN101987136A Medicine for treating neurodermatitis and preparation method thereof |
| 03/23/2011 | CN101987131A Medicine for treating neurasthenia |
| 03/23/2011 | CN101987094A Ornithine aspartate injection and preparation method thereof |
| 03/23/2011 | CN101987091A Venlafaxine hydrochloride sustained-release pellet capsules |
| 03/23/2011 | CN101987090A Fluoxetine capsule and preparation method thereof |
| 03/23/2011 | CN101856457B Medicine with kidney tonifying, essence replenishing and yang invigorating functions and preparation method thereof |
| 03/23/2011 | CN101670038B Compound fleece-flower root extract capsule and preparation method and usage thereof |
| 03/23/2011 | CN101596200B Preparation of compound of cycloartenyl ferulate and purification process thereof |
| 03/23/2011 | CN101485640B Huperzine A mono-layer osmotic pump controlled release tablets |
| 03/23/2011 | CN101406670B Chinese patent medicine for treating brain injury coma |
| 03/23/2011 | CN101328221B Hypoglycemic polypeptide fused protein, structure and use of derivate thereof |
| 03/23/2011 | CN101199830B Heat-transfer dose medicament for treating migraine |
| 03/23/2011 | CN101175751B Crystal of indole derivative having piperidine ring and process for production thereof |
| 03/23/2011 | CN101161280B Medicine for curing epilepsy |
| 03/22/2011 | US7910739 tacrine derivatives such as N-[5(6-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamino)pentyl]-3-(1H-indol-3-yl) propionamide, used for treatment of neurodegenerative diseases; bioassays |
| 03/22/2011 | US7910709 Thyroid stimulating hormone for use in diagnosis, prevention and treatment of thyroid gland disorders |
| 03/22/2011 | US7910617 Method for suppressing the number of peripheral blood lymphocytes using an amino alcohol compound |
| 03/22/2011 | US7910605 Administering tertiary amines, e.g., 3,3-Dimethylbutyl 3-piperidinopropyl ether, 3-Phenylpropyl 3-piperidinopropyl ether, or3-(4-Chlorophenyl)propyl 3-piperidinopropyl ether to treat cognitive disorders such as attention, wakefulness and memory disorders |
| 03/22/2011 | US7910591 e.g. 3-[4-(4-Pyridine-2-yl-piperazine-1-yl)-butyl]-1,3-dihydro-2H-indol-2-one; serotonin 5-HT7 and alpha 1 receptors modulator; antxiolytic agent, antidepressant; neurodegenerative diseases; schizophrenia, Alzheimer's disease, stroke, dementias; side effect reduction |
| 03/22/2011 | US7910589 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 03/22/2011 | US7910586 Drug screening; administering secretase inhibitor; Alzheimer's disease |
| 03/22/2011 | US7910370 Treating and preventing cell proliferative, neurodegenerative and viral infections via enhancing oncogenic protein expression |
| 03/22/2011 | US7910320 Methods compositions and compound assays for inhibiting amyloid-beta protein production |
| 03/22/2011 | US7910132 Pharmaceutical composition for the treatment of acute disorders |
| 03/22/2011 | CA2615856C Use of dopamine d2/d3 receptor agonists to treat fibromyalgia |
| 03/22/2011 | CA2569742C Opioids for the treatment of the restless leg syndrome |
| 03/22/2011 | CA2536149C Stable polymorph of bifeprunox mesilate(7-(4-(1,1'-biphenyl)-3-ylmethyl)-1-piperazinyl)-2(3h)-benzoxazolone monomethanesulfonate) |
| 03/22/2011 | CA2492342C Novel bio-active pyrimidine derivatives |
| 03/22/2011 | CA2490531C Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity |
| 03/22/2011 | CA2488001C 1,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma |
| 03/22/2011 | CA2487238C Hydroxy tetrahydro-naphthalenylurea derivatives |
| 03/22/2011 | CA2480273C Ph-sensitive polymer |
| 03/22/2011 | CA2479363C Thiopyrimidine and isothiazolopyrimidine kinase inhibitors |
| 03/22/2011 | CA2478229C Pyridinoylpiperidines as 5-ht1f agonists |
| 03/22/2011 | CA2473885C Use of ambroxol in the treatment of chronic pains, cerebral excitotoxicity-related disorders and cardiac arrhythmias |
| 03/22/2011 | CA2471769C Oral insulin therapy |
| 03/22/2011 | CA2471628C Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, their preparation and their therapeutic application |
| 03/22/2011 | CA2471538C Pyrrolopyrimidines |
| 03/22/2011 | CA2464735C An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
| 03/22/2011 | CA2450587C Natural ligand of g protein coupled receptor chemr23 and uses thereof |
| 03/22/2011 | CA2449215C (pyrido/thieno)-[f]-oxazepin-5-one derivatives as positive modulators of the ampa receptor |
| 03/22/2011 | CA2433675C Pharmaceutically active piperidine derivatives |
| 03/22/2011 | CA2433603C Kappa opioid receptor ligands |
| 03/22/2011 | CA2427072C N-alkylglycine trimers capable of protecting neurons against excitotoxic aggressions and compositions containing said trimers |
| 03/22/2011 | CA2416819C Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| 03/22/2011 | CA2390166C Hedgehog fusion proteins and uses |
| 03/22/2011 | CA2240409C Mammalian cx3c chemokine genes |
| 03/22/2011 | CA2236159C Vp antigens of the jc virus |
| 03/17/2011 | WO2011032161A2 Vaccines directed to langerhans cells |
| 03/17/2011 | WO2011031818A2 Histamine h3 inverse agonists and antagonists and methods of use thereof |
| 03/17/2011 | WO2011031816A2 Histamine h3 inverse agonists and antagonists and methods of use thereof |
| 03/17/2011 | WO2011031350A1 Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof |
| 03/17/2011 | WO2011031327A2 Nicotine haptens, immunoconjugates and their uses |
| 03/17/2011 | WO2011031317A2 Vaccine for control of trypanosoma cruzi infection and chagas disease |
| 03/17/2011 | WO2011031100A2 Aripiprazole-bentonite-aea hybrid, pharmaceutical composition containing the same and method for preparing the same |
| 03/17/2011 | WO2011030798A1 8-oxodihydropurine derivative |
| 03/17/2011 | WO2011030575A1 Therapeutic agent for chronic pain |
| 03/17/2011 | WO2011030349A1 L -dihydro-2-oxoquinoline compounds a 5-ht4 receptor ligands |
| 03/17/2011 | WO2011030224A2 Paliperidone or a pharmaceutically acceptable salt thereof substantially free of impurities |
| 03/17/2011 | WO2011029920A1 Heterocylcic derivatives as inhibitors of glutaminyl cyclase |
| 03/17/2011 | WO2011029775A1 [1,2,4]TRIAZOLO [1,5-c]PYRIMIDINE DERIVATIVES AS Hsup90 MODULATORS |
| 03/17/2011 | WO2011029614A1 Crystalline modifications of 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol |
| 03/17/2011 | WO2011029176A1 Concentration and mental performance amplifying formulation |
| 03/17/2011 | WO2011008312A3 Indole and indoline derivatives and methods of use thereof |
| 03/17/2011 | WO2010121834A3 Irak kinase family as novel target and biomarker for alzheimer |
| 03/17/2011 | WO2010028776A8 Piperazine derivatives for binding and imaging amyloid plaques and their use |
| 03/17/2011 | US20110067123 Mao-b elevation as an early parkinson's disease biomarker |
| 03/17/2011 | US20110066112 Reduced volume formulation of glatiramer acetate and methods of administration |
| 03/17/2011 | US20110066111 Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof |
| 03/17/2011 | US20110066100 Methods for iontophoretically treating nausea and migraine |
| 03/17/2011 | US20110065938 Method for the preparation of escitalopram |
| 03/17/2011 | US20110065796 Prodrugs of guanfacine |
| 03/17/2011 | US20110065793 Highly purified ethyl epa and other epa derivatives |
| 03/17/2011 | US20110065778 RNA Interference Mediated Inhibition of Muscarinic Colinergic Receptor Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 03/17/2011 | US20110065770 Formulations comprising antisense nucleotides to connexins |
| 03/17/2011 | US20110065764 5- phenyl-isoxazole-3-carboxamide derivatives as trpv1 modulators |
| 03/17/2011 | US20110065760 Compounds for the inhibition of rotamases and use thereof |
| 03/17/2011 | US20110065757 Methods for treatment of kallikrein-related disorders |
| 03/17/2011 | US20110065749 Method and pharmaceutical composition for treatment of mental disorders |
| 03/17/2011 | US20110065747 Compositions and methods for treating seizure disorders |
| 03/17/2011 | US20110065745 Polysubstituted 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives, and preparation and therapeutic use thereof |
| 03/17/2011 | US20110065743 Kappa opioid receptor ligands |
| 03/17/2011 | US20110065730 6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines |
| 03/17/2011 | US20110065727 POLYSUBSTITUTED DERIVATIVES OF 2-HETEROARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF |
| 03/17/2011 | US20110065725 Triazole amide derivatives for use in therapy |
| 03/17/2011 | US20110065720 Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases |
| 03/17/2011 | US20110065716 Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 03/17/2011 | US20110065715 Nogo Receptor Binding Small Molecules to Promote Axonal Growth |
| 03/17/2011 | US20110065713 Benzazole Derivatives, Compositions, and Methods of Use as B-Secretase Inhibitors |
| 03/17/2011 | US20110065711 Substituted triazolo-pyridazine derivatives |